stock
FDMT · 4D Molecular Therapeutics, Inc.
What 4D Molecular Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live FDMT price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on FDMT.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- Not reported.
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -214.2%
- Net
- -194.7%
Returns
- ROE
- -44.0%
- ROA
- -36.4%
Health
- Current ratio
- 8.0x
- Debt/equity
- 0.0x
Deep value
- NCAV
- $298.00M
- NCAV per share
- —
- Price/NCAV
- Locked
- NNWC
- -$14.58M
- NNWC per share
- —
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $3.78M | —Gross profit: unreported by this company. | -$77.03M | -$72.94M | 10-Q filed 2026-08-13 |
| 2026-03-31 | $3.05M | —Gross profit: unreported by this company. | -$73.62M | -$68.76M | 10-Q filed 2026-08-13 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $85.09M | —Gross profit: unreported by this company. | $14.71M | $19.40M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $90,000 | —Gross profit: unreported by this company. | -$61.19M | -$56.88M | 10-Q filed 2025-11-10 |
| 2025-06-30 | $15,000 | —Gross profit: unreported by this company. | -$59.46M | -$54.66M | 10-Q filed 2026-08-13 |
| 2025-03-31 | $14,000 | —Gross profit: unreported by this company. | -$53.62M | -$47.97M | 10-Q filed 2026-08-13 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $1,000 | —Gross profit: unreported by this company. | -$56.12M | -$49.67M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $3,000 | —Gross profit: unreported by this company. | -$51.13M | -$43.84M | 10-Q filed 2025-11-10 |
- Assets
- $492.62M
- Equity
- $407.66M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $85.21M | -$159.55M | -$140.11M | -$109.62M |
| 2024-12-31 | $37,000 | -$187.84M | -$160.87M | -$138.37M |
| 2023-12-31 | $20.72M | -$112.87M | -$100.84M | -$78.56M |
| 2022-12-31 | $3.13M | -$110.03M | -$107.49M | -$98.22M |
| 2021-12-31 | $18.04M | -$71.33M | -$71.32M | -$78.24M |
| 2020-12-31 | $13.36M | -$56.66M | -$56.69M | -$51.91M |
| 2019-12-31 | $6.96M | -$50.76M | -$49.31M | -$39.91M |
Company filings
since Thu May 7 · 1 offering filing in 12 months · since Thu Nov 6
events
5% owners ()
RA Capital Management, L.P.
Stake update
BIOTECHNOLOGY VALUE FUND L P
Stake update
STATE STREET CORPORATION
Passive stake
JANUS HENDERSON GROUP PLC
Stake update
The Vanguard Group
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Bizily Scott
Chief Legal Officer
Sale$22,318Sep 22, 6:43 PM ET
Kirn David
See Remarks, Director
Sale$811,004Sep 16, 5:13 PM ET
Bizily Scott
Chief Legal Officer
Sale$8,176Sep 3, 6:55 PM ET
Kirn David
See Remarks, Director
Sale$1,088,273Aug 21, 4:06 PM ET
Bizily Scott
Chief Legal Officer
Sale$39,567Aug 17, 5:34 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named FDMT, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about FDMT.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on FDMT come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the FDMT board